Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453583 · ClinicalTrials.gov registry record
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
A clinical trial, sponsored by UCB Pharma.
- Completed
- Registry status
- 4,581
- Enrollment target
NCT00453583 is a clinical trial that has completed, run by UCB Pharma. The registered enrollment target is 4,581 participants.
The verdict
NCT00453583 has completed, sponsored by UCB Pharma.
- COMPLETED
- Registry status
- 4,581 participants
- Enrollment target
Study Summary
This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,581 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00453583
The ClinicalTrials.gov registry entry for NCT00453583 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,581 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCB Pharma, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00453583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00453583 about?
NCT00453583 is a clinical study titled "Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine". This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents...
What is the current status of trial NCT00453583?
This trial is currently completed. The enrollment target is 4,581 participants. The study started on 2007-03. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00453583?
This trial is sponsored by UCB Pharma, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.